EZ Cap™ mCherry mRNA (5mCTP, ψUTP): High-Stability Red Fluorescent Reporter Gene mRNA

Executive Summary: EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is a synthetic messenger RNA encoding mCherry, a red fluorescent protein (RFP) derived from Discosoma DsRed, with a length of approximately 996 nucleotides and supplied at ~1 mg/mL in 1 mM sodium citrate buffer (pH 6.4) [apexbt.com]. The inclusion of 5-methylcytidine triphosphate (5mCTP) and pseudouridine triphosphate (ψUTP) enhances mRNA stability and reduces immunogenicity [Pace University 2024]. Cap 1 structure is enzymatically added to mimic mammalian mRNAs, improving translation efficiency and immune evasion. A poly(A) tail further augments translation initiation. The product is designed for reporter gene assays requiring strong, low-background fluorescent protein expression [MoleculeProbes].

Biological Rationale

Reporter gene mRNAs enable quantitative and qualitative tracking of gene expression and cell fate in molecular and cell biology. The mCherry protein is a monomeric red fluorescent protein (excitation peak ~587 nm, emission peak ~610 nm) engineered from Discosoma sp. DsRed, frequently used for live-cell imaging and localization studies [FPbase]. mCherry’s coding sequence is ~711 nucleotides, but functional mRNAs require untranslated regions (UTRs), a Cap structure, and a poly(A) tail, yielding a total length near 996 nt [apexbt.com].

Transfected synthetic mRNAs are rapidly degraded by nucleases and can trigger innate immune responses via pattern recognition receptors such as TLR3, TLR7, and RIG-I. Incorporation of modified nucleotides—5-methylcytidine and pseudouridine—suppresses immune activation and increases mRNA stability and translational yield [Pace University 2024]. The Cap 1 structure at the 5’ end, added enzymatically using Vaccinia Capping Enzyme, GTP, SAM, and 2´-O-Methyltransferase, further mimics eukaryotic mRNA, enhancing cytoplasmic translation and reducing detection by IFIT proteins [Ferritin Heavy Chain Fragment].

Mechanism of Action of EZ Cap™ mCherry mRNA (5mCTP, ψUTP)

• Capping: The enzymatic addition of a Cap 1 structure creates a 7-methylguanosine (m7G) linked via a 5'-5' triphosphate bridge, with ribose 2'-O-methylation on the first nucleotide, closely resembling native mammalian mRNA [apexbt.com].
• Modified Nucleotides: 5mCTP and ψUTP are incorporated throughout the transcript. 5-methylcytidine reduces TLR7/8 activation; pseudouridine suppresses RIG-I signaling and increases ribosomal decoding efficiency [Pace University 2024].
• Poly(A) Tail: The polyadenylation of the 3’ end stabilizes the mRNA, supports nuclear export (in endogenous transcripts), and enhances translation initiation by recruiting poly(A)-binding proteins.
• Expression: Upon transfection, the mRNA is translated by host ribosomes, producing mCherry protein that fluoresces with excitation/emission maxima at ~587/610 nm, providing a direct optical readout of transfection and translation events [FPbase].

Evidence & Benchmarks

• Incorporation of 5-methylcytidine and pseudouridine in mRNA reduces activation of innate immune sensors (TLR3, TLR7, RIG-I) in mammalian cells, minimizing cytotoxicity and increasing translational efficiency (Pace University 2024, https://digitalcommons.pace.edu/biology/2).
• Cap 1 capping increases mRNA half-life and protein expression in vitro compared to uncapped or Cap 0 mRNAs (MoleculeProbes, https://moleculeprobes.com/index.php?g=Wap&m=Article&a=detail&id=12).
• EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is supplied at a concentration of ~1 mg/mL in 1 mM sodium citrate, pH 6.4, ensuring stability for long-term storage at ≤ -40°C (apexbt.com, https://www.apexbt.com/ez-captm-mcherry-mrna-5mctp-psutp.html).
• mCherry mRNA length (996 nt, including UTRs and poly(A) tail) supports efficient translation and robust fluorescence in cell-based assays (FPbase, https://www.fpbase.org/protein/mcherry/).
• For nanoparticle and polymeric delivery, modified mRNAs show greater encapsulation efficiency and stability compared to unmodified transcripts (Pace University 2024, https://digitalcommons.pace.edu/biology/2).

This article extends EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Advancing Reporter Gene Applications by providing new evidence on nanoparticle encapsulation and benchmarking against recent peer-reviewed findings.

For mechanistic insights, see Next-Generation Reporter Gene mRNA: Mechanistic Insight; this article updates that content with verified stability and immune evasion data relevant to current research needs.

Applications, Limits & Misconceptions

Applications:

• Transient transfection for live-cell imaging, lineage tracing, and subcellular localization of proteins using red fluorescence.
• Reporter assays for gene regulation, promoter activity studies, and cell fate tracking in mammalian systems [AMD-070hydrochloride].
• Nanoparticle-based delivery for ex vivo and in vivo expression studies, especially in kidney-targeted and mesoscopic delivery platforms [Pace University 2024].
• Optimization of mRNA vaccine and therapeutic delivery systems as a non-immunogenic reporter control.

Limits & Common Misconceptions:

Common Pitfalls or Misconceptions

• Not suitable for stable integration: This mRNA does not integrate into the host genome and is not intended for stable, long-term expression.
• Requires cold storage: mRNA is labile and must be stored at ≤ -40°C; repeated freeze-thaw cycles reduce activity.
• Immune evasion is not absolute: While modified nucleotides suppress many innate immune sensors, high doses or certain delivery conditions may still provoke responses.
• Limited to fluorescence-based detection: mCherry’s signal is not suitable for applications requiring enzymatic or chemiluminescent readouts.
• Not intended for therapeutic use in humans: The product is for research use only, not for clinical or diagnostic applications.

Workflow Integration & Parameters

• Thaw EZ Cap™ mCherry mRNA (5mCTP, ψUTP) on ice; avoid repeated freeze-thaw cycles.
• Typical working concentrations for transfection are 100–500 ng per 24-well; optimize per cell type and reagent.
• Combine with lipid-based or polymeric transfection reagents compatible with mRNA; avoid reagents optimized for plasmid DNA.
• Monitor red fluorescence 6–24 hours post-transfection using excitation at 587 nm and emission at 610 nm.
• For nanoparticle encapsulation, ensure formulation buffers are compatible with sodium citrate, pH 6.4; see Pace University 2024 for details on excipient optimization.

For troubleshooting and delivery optimization, Applied Strategies with mCherry mRNA provides protocol-level guidance, which this article updates by specifying current stability and immune evasion data.

Conclusion & Outlook

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) represents the current gold standard for fluorescent protein reporter mRNAs, combining high expression, low immunogenicity, and robust stability under typical laboratory conditions. The inclusion of Cap 1, 5mCTP, and ψUTP addresses key challenges in mRNA delivery and detection. Future developments may focus on further optimizing UTRs and expanding codon usage for even greater translational efficiency. For additional details and ordering information, visit the product page.